User profiles for Piotr Chmielarz
Piotr ChmielarzMaj Institute of Pharmacology, PAS Verified email at helsinki.fi Cited by 868 |
[HTML][HTML] Interplay between MicroRNAs and oxidative stress in neurodegenerative diseases
…, D Gerasymchuk, I Parkkinen, P Chmielarz… - International journal of …, 2019 - mdpi.com
MicroRNAs are post-transcriptional regulators of gene expression, crucial for neuronal
differentiation, survival, and activity. Age-related dysregulation of microRNA biogenesis increases …
differentiation, survival, and activity. Age-related dysregulation of microRNA biogenesis increases …
[HTML][HTML] Neuroprotective effects of pomegranate juice against Parkinson's disease and presence of ellagitannins-derived metabolite—urolithin A—in the brain
…, M Kurpik, M Szulc, H Szaefer, P Chmielarz… - International journal of …, 2019 - mdpi.com
Pomegranate juice is a rich source of ellagitannins (ETs) believed to contribute to a wide range
of pomegranate’s health benefits. While a lot of experimental studies have been devoted …
of pomegranate’s health benefits. While a lot of experimental studies have been devoted …
[HTML][HTML] Dicer and microRNAs protect adult dopamine neurons
MicroRNAs (miRs) are important post-transcriptional regulators of gene expression
implicated in neuronal development, differentiation, aging and neurodegenerative diseases, …
implicated in neuronal development, differentiation, aging and neurodegenerative diseases, …
[HTML][HTML] Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies
P Chmielarz, M Saarma - Pharmacological Reports, 2020 - Springer
Background Neurotrophic factors are endogenous proteins promoting the survival of
different neural cells. Therefore, they elicited great interest as a possible treatment for …
different neural cells. Therefore, they elicited great interest as a possible treatment for …
[HTML][HTML] Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo
A molecular hallmark in Parkinson's disease (PD) pathogenesis are α-synuclein aggregates.
Cerebral dopamine neurotrophic factor (CDNF) is an atypical growth factor that is mostly …
Cerebral dopamine neurotrophic factor (CDNF) is an atypical growth factor that is mostly …
GDNF/RET signaling pathway activation eliminates Lewy body pathology in midbrain dopamine neurons
Background Parkinson's disease (PD) is associated with proteostasis disturbances and
accumulation of misfolded α‐synuclein (α‐syn), a cytosolic protein present in high …
accumulation of misfolded α‐synuclein (α‐syn), a cytosolic protein present in high …
Back and to the future: from neurotoxin‐induced to human Parkinson's disease models
Parkinson's disease (PD) is an age‐related neurodegenerative disorder characterized by
motor symptoms such as tremor, slowness of movement, rigidity, and postural instability, as …
motor symptoms such as tremor, slowness of movement, rigidity, and postural instability, as …
Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects
…, WA Daniel, A Nikiforuk, I Nalepa, P Chmielarz… - European Journal of …, 2018 - Elsevier
Currently used antipsychotics are characterized by multireceptor mode of action. While
antagonism of dopamine D 2 receptors is responsible for the alleviation of “positive” symptoms of …
antagonism of dopamine D 2 receptors is responsible for the alleviation of “positive” symptoms of …
MANF ablation causes prolonged activation of the UPR without neurodegeneration in the mouse midbrain dopamine system
E Pakarinen, T Danilova, V Võikar, P Chmielarz… - ENeuro, 2020 - eneuro.org
Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an endoplasmic reticulum (ER)
localized protein that regulates ER homeostasis and unfolded protein response (UPR). …
localized protein that regulates ER homeostasis and unfolded protein response (UPR). …
Studying pre-formed fibril induced α-synuclein accumulation in primary embryonic mouse midbrain dopamine neurons
The goal of this protocol is to establish a robust and reproducible model of α-synuclein
accumulation in primary dopamine neurons. Combined with immunostaining and unbiased …
accumulation in primary dopamine neurons. Combined with immunostaining and unbiased …